FDA Public Workshop on Coordinated Development of Antimicrobial Drugs and Antimicrobial Susceptibility Test Devices (ASTs)- Drug Information Update

The Division of Drug Information (DDI)- serving the public by providing information on human drug products and drug product regulation by FDA.

The Food and Drug Administration (FDA or agency) is announcing a public workshop regarding Coordinated Development of Antimicrobial Drugs and Antimicrobial Susceptibility Test Devices (ASTs). This public workshop is intended to facilitate discussion between drug sponsors and device manufacturers who are planning to develop new antimicrobial drugs or ASTs and who wish to coordinate development of these products, such that the AST device could be cleared either at the time of new drug approval or shortly thereafter. The input from this public workshop will also help in developing topics for future discussion.

Date: September 29, 2016

Time: 9:00 a.m. to 4:00 p.m.

Location: The public workshop will be held at the Sheraton Silver Spring Hotel, 8777 Georgia Ave., Silver Spring, MD 20910. The hotel’s phone number is 301-589-0800.

Registration: Registration is free for the public workshop. Interested parties are encouraged to register early. Seating will be available on a first-come, first-served basis. To register electronically, e-mail your registration information (including name, title, firm name, address, telephone number, and fax number) toAntimicrobialSusceptibilitytestingWorkshop2016@fda.hhs.gov. Persons without access to the Internet can call 301-796-1300 to register. If you need special accommodations due to a disability, please contact Jessica Barnes or Lori Benner (see Contact Persons above) at least 7 days in advance.

For more information, please visit: ASTs Public Workshop.